N@N

STAAR Surgical Announces First Quarter 2013 Results Release Date And Conference Call And Webcast

_{//health-fitness.news-articles.net/content/2013/ .. elease-date-and-conference-call-and-webcast.html}
^{Published in Health and Fitness on Monday, April 22nd 2013 at 4:00 GMT by Market Wire}  

STAAR Surgical Announces First Quarter 2013 Results Release Date And Conference Call... -- MONROVIA, Calif., April 22, 2013 /PRNewswire/ --

MONROVIA, Calif., April 22, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: [ STAA ]) today announced that it will release its financial results for the first quarter ended March 29, 2013 on Wednesday, May 1, 2013after the market close.  The Company will host a conference call and webcast on Wednesday, May 1, 2013 at 4:30 p.m. Eastern / 1:30 p.m.Pacific to discuss the Company's first quarter results and recent corporate developments. The dial-in number for the conference call is 877-703-6110 for domestic participants and 857-244-7309 for international participants, both using the passcode 23245755.

The Company will also be using slides to illustrate its first quarter results and operational progress.  The slides and live webcast of the call can be accessed from the investor relations section of the STAAR website at [ www.staar.com ].   

A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will be available for seven days.  This replay can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers, both using passcode 40120994  An archived webcast will also be available at [ www.staar.com ].

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye and delivery systems therefor. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 350,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: [ www.visianinfo.com ]. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at [ www.staar.com ].

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material. 

SOURCE STAAR Surgical Company